Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
$29.5K Buy
39,005
+6,283
+19% +$5.83K ﹤0.01% 669
2022
Q4
$31.4K Sell
32,722
-4,609
-12% -$6.51K ﹤0.01% 505
2022
Q3
$81K Sell
37,331
-2,618
-7% -$9.03K ﹤0.01% 659
2022
Q2
$141K Buy
39,949
+1,787
+5% +$6.68K ﹤0.01% 667
2022
Q1
$190K Buy
38,162
+295
+0.8% +$1.49K ﹤0.01% 605
2021
Q4
$244K Sell
37,867
-6,070
-14% -$41.4K ﹤0.01% 604
2021
Q3
$352K Buy
43,937
+7,866
+22% +$64.7K 0.01% 583
2021
Q2
$298K Sell
36,071
-19
-0.1% -$133 ﹤0.01% 584
2021
Q1
$209K Sell
36,090
-17,155
-32% -$132K ﹤0.01% 612
2020
Q4
$318K Sell
53,245
-8,086
-13% -$51.4K 0.01% 539
2020
Q3
$419K Buy
61,331
+39,041
+175% +$348K 0.01% 345
2020
Q2
$167K Buy
+22,290
New +$64K 0.01% 565

Other funds holding VXRT

ETF Managers Group's VXRT Position: Q1 2023 in Review

ETF Managers Group increased its Vaxart (VXRT) stake by 19% in Q1 2023, buying an estimated $5.83K and bringing the position to 39,005 shares worth $29.5K. The position accounts for ﹤0.01% of the portfolio, ranked #669.

ETF Managers Group first reported a position in VXRT in Q2 2020 and has held it in 12 quarters since. The position peaked at $419K in Q3 2020. 109 funds tracked by Wall St. Rank hold VXRT as of Q1 2023.

  • ETF Managers Group held 39,005 shares of Vaxart worth $29.5K as of Q1 2023.
  • ETF Managers Group bought 6,283 Vaxart shares in Q1 2023, an estimated $5.83K.
  • Vaxart made up ﹤0.01% of ETF Managers Group's portfolio in Q1 2023, its #669 holding.
  • ETF Managers Group first reported a position in Vaxart in Q2 2020 and has held it in 12 quarters since.
  • ETF Managers Group's Vaxart position peaked at $419K in Q3 2020.
  • 109 funds tracked by Wall St. Rank held Vaxart as of Q1 2023.

Based on ETF Managers Group's 13F filing for Q1 2023, filed 18 Apr 2023.